| 1 |
31149552 | Acute arteritis after G-CSF administration. | 2019 Apr |
1 |
| 2 |
28679984 | A case of a patient with granulocyte-colony stimulating factor-producing pancreatic cancer who responded to nab-paclitaxel plus gemcitabine. | 2017 |
1 |
| 3 |
27721193 | Variation in the use of granulocyte-colony stimulating factor for dose dense paclitaxel: A single institution retrospective study. | 2016 Dec |
2 |
| 4 |
26049123 | Phase II study of weekly paclitaxel/carboplatin in combination with prophylactic G-CSF in the treatment of gynecologic cancers: A study in 108 patients by the Belgian Gynaecological Oncology Group. | 2015 Aug |
1 |
| 5 |
24625457 | Plerixafor added to G-CSF-supported paclitaxel-ifosfamide-cisplatin salvage chemotherapy enhances mobilization of adequate numbers of hematopoietic stem cells for subsequent autografting in hard-to-mobilize patients with relapsed/refractory germ-cell tumors: a single-center experience. | 2014 Aug |
1 |
| 6 |
25648659 | Comparison of Therapeutic G-CSF Cycles and Prophylactic G-CSF Cycles in Patients Receiving Paclitaxel and Carboplatin Combination Chemotherapy for Ovarian Cancer: A Retrospective Study Report. | 2014 |
3 |
| 7 |
23686402 | Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review. | 2013 Oct |
1 |
| 8 |
20947484 | Cost-effectiveness analyses of docetaxel versus paclitaxel once weekly in patients with metastatic breast cancer in progression following anthracycline chemotherapy, in Spain. | 2010 Oct |
2 |
| 9 |
18751888 | A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma. | 2009 Jun |
1 |
| 10 |
19218307 | Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancer. | 2009 Jul |
1 |
| 11 |
18006110 | Prophylactic G-CSF and antibiotics enable a significant dose-escalation of triplet-chemotherapy in non-small cell lung cancer. | 2008 May |
1 |
| 12 |
18455782 | Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study. | 2008 Jul |
1 |
| 13 |
18644619 | Paclitaxel, topotecan, and carboplatin in metastatic endometrial cancinoma: a Hellenic Co-operative Oncology Group (HeCOG) study. | 2008 Oct |
1 |
| 14 |
17762397 | Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II study. | 2007 Jul |
2 |
| 15 |
16520664 | Weekly paclitaxel, 5-fluorouracil and folinic acid with granulocyte colony-stimulating factor support in metastatic breast cancer patients: a phase II study. | 2006 Mar |
2 |
| 16 |
17409984 | Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914. | 2006 Nov |
1 |
| 17 |
16020968 | Biweekly docetaxel-irinotecan treatment with filgrastim support is highly active in antracycline-Paclitaxel-refractory breast cancer patients. | 2005 |
1 |
| 18 |
15181605 | Dose-dense chemotherapy in breast cancer and lymphoma. | 2004 Jun |
2 |
| 19 |
15197811 | A phase I study of sequential administration of escalating doses of intravenous paclitaxel, oral topotecan, and fixed-dose oral etoposide in patients with solid tumors. | 2004 Jun 15 |
1 |
| 20 |
15899616 | [Dose density and dose intensity in the treatment of breast cancer]. | 2004 Dec 1 |
1 |
| 21 |
12743738 | Phase I and pharmacokinetic study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer. | 2003 Jul |
1 |
| 22 |
14703065 | Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability. | 2003 Dec |
1 |
| 23 |
11953891 | Modulation of colony stimulating factor release and apoptosis in human colon cancer cells by anticancer drugs. | 2002 Apr 22 |
1 |
| 24 |
11181665 | Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study. | 2001 Feb 15 |
1 |
| 25 |
11201384 | [Recurrent breast cancer successfully treated with a weekly dose of paclitaxel--a case report]. | 2001 Jan |
1 |
| 26 |
11336465 | A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study. | 2001 May 4 |
1 |
| 27 |
11489808 | Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology Group. | 2001 Aug |
1 |
| 28 |
11735678 | Paclitaxel: a pharmacoeconomic review of its use in non-small cell lung cancer. | 2001 |
1 |
| 29 |
11843253 | Phase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumors. | 2001 Dec |
1 |
| 30 |
10864197 | Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer. | 2000 Jun |
1 |
| 31 |
10873410 | Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: long-term results of a phase II multicenter study. | 2000 Jul |
1 |
| 32 |
11006039 | Cisplatin-paclitaxel-cyclophosphamide with G-CSF in primary advanced epithelial ovarian cancer. | 2000 Oct |
1 |
| 33 |
11016746 | Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase II study. | 2000 Jul |
1 |
| 34 |
11079171 | A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus. | 2000 Sep-Oct |
1 |
| 35 |
10053098 | A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer. | 1999 Mar |
1 |
| 36 |
10071279 | Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer. | 1999 Mar |
1 |
| 37 |
10355583 | Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: a dose-finding study. | 1999 Mar |
1 |
| 38 |
10430075 | Phase I and pharmacologic study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumors. | 1999 Jul |
2 |
| 39 |
10447584 | Pharmacokinetics of paclitaxel administered in combination with cisplatin, etoposide and bleomycin in patients with advanced solid tumours. | 1999 |
2 |
| 40 |
10521070 | Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group. | 1999 Oct |
1 |
| 41 |
10561191 | Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a randomized comparison. | 1999 Apr |
1 |
| 42 |
9626789 | Paclitaxel (Taxol) plus doxorubicin plus filgrastim in advanced sarcoma: a phase II study. | 1998 Jun |
1 |
| 43 |
9681085 | A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer. | 1998 Jun |
1 |
| 44 |
9694607 | Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study. | 1998 May |
1 |
| 45 |
9740541 | Phase I study of paclitaxel (taxol) and granulocyte colony stimulating factor (G-CSF) in patients with unresectable malignancy. | 1998 |
5 |
| 46 |
9043028 | Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study. | 1997 |
1 |
| 47 |
9045339 | Study of escalating doses of paclitaxel plus cisplatin in patients with inoperable head and neck cancer. | 1997 Feb |
1 |
| 48 |
9053494 | Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor. | 1997 Feb |
3 |
| 49 |
9053499 | Paclitaxel by 96-hour continuous infusion in combination with cisplatin: a phase I trial in patients with advanced lung cancer. | 1997 Feb |
2 |
| 50 |
9144683 | Cisplatin/etoposide vs paclitaxel/cisplatin/G-CSF vs paclitaxel/cisplatin in non-small-cell lung cancer. | 1997 Apr |
1 |